Who is sponsoring NCT01651962?

NCT01651962 is sponsored by Kai Schoenhage.

What condition does NCT01651962 study?

NCT01651962 studies Labor Pain.

What drugs are being tested in NCT01651962?

Interventions: Terbutaline, Fentanyl, 0.9% NaCl.

What is the status of NCT01651962?

NCT01651962 is currently UNKNOWN.

Last reviewed 2015-01-15 · How we verify

Intravenous Terbutaline to Facilitate Epidural Catheter Placement for Parturients With Labor Pain

NCT01651962 Phase 4 UNKNOWN

Labor pain is a major factor in making the placement of an epidural catheter difficult. The epidural, once in place and dosed, eventually decreases the parturient's pain. To achieve this goal as fast and safely as possible it would be helpful to have a parturient who can tolerate and co-operate with the placement of the epidural catheter. Briefly stopping contractions, the cause of labor pain, could be the key to achieve this goal. This study will evaluate the safety, efficacy and duration of the drug terbutaline for this purpose.

Details

Lead sponsor	Kai Schoenhage
Phase	Phase 4
Status	UNKNOWN
Enrolment	250
Start date	2012-08
Completion	2015-12

Conditions

Labor Pain

Interventions

Terbutaline
Fentanyl
0.9% NaCl

Primary outcomes

reduction of pain score on a visual analog scale (VAS) of 1-10 — 0-30 minutes
semi-quantitative assessment of decrease in the subject's pain score after administration of the study drug for the placement of an epidural catheter

Countries

United States